XML 13 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)        
Grant income $ 195,874 $ 108,938 $ 530,106 $ 386,121
Operating Expenses:        
Research and development 3,969,070 2,965,512 12,680,430 9,269,772
General and administrative 3,192,403 2,353,525 8,389,821 5,667,510
Total operating expenses 7,161,473 5,319,037 21,070,251 14,937,282
Operating loss (6,965,599) (5,210,099) (20,540,145) (14,551,161)
Other income 1,845 18,448 38,741 54,575
Loss on derivative instruments (1,282,829) (7,905,519) (3,565,347) (3,316,384)
Warrant inducement expense (805,753) 0 (805,753) 0
Other non-operating gains (950,935) 1,455,844 774,245 1,877,197
Interest expense, net (273,708) (443,442) (777,898) (1,350,774)
Net loss     (24,876,157) (17,286,547)
Modification of warrants   0 (21,734) 0
Net loss available to common shareholders $ (10,276,979) $ (12,084,768) $ (24,897,891) $ (17,286,547)
Net loss per common share - basic and diluted $ (0.27) $ (0.37) $ (0.69) $ (0.58)
Weighted average common shares outstanding - basic and diluted 37,453,539 33,051,888 36,230,092 30,046,241